Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
Mitochondrial dysfunction is a common pathological hallmark in various inflammatory and degenerative diseases of the central nervous system, including multiple sclerosis (MS). We previously showed that oxidative stress alters axonal mitochondria, limiting their transport and inducing conformational...
Main Authors: | Bimala Malla, Samuel Cotten, Rebecca Ulshoefer, Friedemann Paul, Anja E. Hauser, Raluca Niesner, Helena Bros, Carmen Infante-Duarte |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-08-01
|
Series: | Therapeutic Advances in Chronic Disease |
Online Access: | https://doi.org/10.1177/2040622320944773 |
Similar Items
-
Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation
by: Ronja Mothes, et al.
Published: (2020-04-01) -
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis
by: Steffen Pfeuffer, et al.
Published: (2021-03-01) -
Teriflunomide in patients with multiple sclerosis
by: N. Y. Lasch, et al.
Published: (2015-12-01) -
An update of teriflunomide for treatment of multiple sclerosis
by: Oh J, et al.
Published: (2013-04-01) -
Teriflunomide promotes oligodendroglial differentiation and myelination
by: Peter Göttle, et al.
Published: (2018-03-01)